VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q58879059  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241120235753.0
008     241120nneanz||abbn n and d
035 ‎‡a  (WKP)Q58879059‏
024 ‎‡a  0000-0003-1324-5448‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q58879059‏
100 0 ‎‡a  Catarina A Marques‏ ‎‡c  researcher ORCID ID = 0000-0003-1324-5448‏ ‎‡9  en‏
375 ‎‡a  2‏ ‎‡2  iso5218‏
400 0 ‎‡a  Catarina A Marques‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's Genome duplication in Leishmania major relies on persistent subtelomeric DNA replication‏
670 ‎‡a  Author's Imidazoquines as antimalarial and antipneumocystis agents‏
670 ‎‡a  Author's Mapping replication dynamics in Trypanosoma brucei reveals a link with telomere transcription and antigenic variation.‏
670 ‎‡a  Author's Plasmodium berghei-infection induces volume-regulated anion channel-like activity in human hepatoma cells‏
670 ‎‡a  Author's Proceedings of the 3rd IPLeiria's International Health Congress : Leiria, Portugal. 6-7 May 2016‏
909 ‎‡a  (orcid) 0000000313245448‏ ‎‡9  1‏
912 ‎‡a  proceedingsofthe3ipleiriasinternationalhealthcongressleiriaportugal67may‏ ‎‡A  Proceedings of the 3rd IPLeiria's International Health Congress : Leiria, Portugal. 6-7 May 2016‏ ‎‡9  1‏
919 ‎‡a  mappingreplicationdynamicsintrypanosomabruceirevealsalinkwithtelomeretranscriptionandantigenicvariation‏ ‎‡A  Mapping replication dynamics in Trypanosoma brucei reveals a link with telomere transcription and antigenic variation.‏ ‎‡9  1‏
919 ‎‡a  imidazoquinesasantimalarialandantipneumocystisagents‏ ‎‡A  Imidazoquines as antimalarial and antipneumocystis agents‏ ‎‡9  1‏
919 ‎‡a  genomeduplicationinleishmaniamajorreliesonpersistentsubtelomericdnareplication‏ ‎‡A  Genome duplication in Leishmania major relies on persistent subtelomeric DNA replication‏ ‎‡9  1‏
919 ‎‡a  plasmodiumbergheiinfectioninducesvolumeregulatedanionchannellikeactivityinhumanhepatomacells‏ ‎‡A  Plasmodium berghei-infection induces volume-regulated anion channel-like activity in human hepatoma cells‏ ‎‡9  1‏
943 ‎‡a  201x‏ ‎‡A  2016‏ ‎‡9  1‏
946 ‎‡a  a‏ ‎‡9  1‏
996 ‎‡2  PTBNP|1763968
996 ‎‡2  LC|nr2004027220
996 ‎‡2  PTBNP|1057566
996 ‎‡2  RERO|A027339944
996 ‎‡2  NTA|436965577
996 ‎‡2  PTBNP|1474961
996 ‎‡2  PTBNP|1679647
996 ‎‡2  ISNI|0000000448634029
996 ‎‡2  ISNI|0000000070731862
996 ‎‡2  ISNI|0000000113784623
996 ‎‡2  PTBNP|1341114
996 ‎‡2  PTBNP|1441038
996 ‎‡2  ISNI|0000000081580756
996 ‎‡2  ISNI|0000000428221892
996 ‎‡2  ISNI|0000000068981299
996 ‎‡2  DNB|1234007428
996 ‎‡2  BNE|XX1399105
996 ‎‡2  ISNI|0000000059401475
996 ‎‡2  ISNI|0000000072451290
996 ‎‡2  PTBNP|1240095
996 ‎‡2  PTBNP|1387070
996 ‎‡2  NSK|000538311
996 ‎‡2  BNF|16784047
996 ‎‡2  BNF|16953680
996 ‎‡2  BLBNB|001582535
996 ‎‡2  NTA|301074054
996 ‎‡2  PTBNP|282162
996 ‎‡2  ISNI|000000007282697X
996 ‎‡2  PTBNP|1445720
996 ‎‡2  PTBNP|1428503
996 ‎‡2  BNE|XX1035552
996 ‎‡2  PTBNP|1456517
996 ‎‡2  DNB|132895374
996 ‎‡2  PTBNP|1731347
996 ‎‡2  LC|n 86853770
996 ‎‡2  PTBNP|1435104
996 ‎‡2  PTBNP|1813550
996 ‎‡2  RERO|A018711268
996 ‎‡2  PTBNP|1888451
996 ‎‡2  SUDOC|18746717X
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏